0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Many cancer patients receiving THC as antiemetic

Phil Gunby
JAMA. 1981;245(15):1515-1518. doi:10.1001/jama.1981.03310400007003.
Text Size: A A A
Published online

ABSTRACT

Tablets containing the active ingredient of marijuana, Δ9-tetrahydrocannabinol (THC), are being distributed by the National Cancer Institute (NCI), Bethesda, Md, for use by some patients undergoing cancer chemotherapy.

The NCI officials estimate that at present 200,000 Americans may be taking drugs to combat cancer. Perhaps 50,000 of these patients experience refractory nausea and, while estimates vary, it is suggested that THC might help about one half of this group.

The potential of THC for combating nausea has been studied since the early 1970s. Not long ago, the Food and Drug Administration finally accepted an advisory committee's recommendation that THC be made available to oncologists for antiemetic therapy (JAMA [MEDICAL NEWS] 1980;243:15-18,1980;244:754).

Marijuana is still illegal for most other uses, however, and under the distribution program for cancer patients, hospital pharmacies that stock THC tablets must be approved by the US Department of Justice's Drug Enforcement Administration (DEA).

Physicians

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();